Therapeutic Potential of Calcium Channel Blockers in Neuropsychiatric, Endocrine and Pain Disorders
Calcium channel blockers (CCBs), originally developed for cardiovascular indications, have gained attention for their therapeutic potential in neuropsychiatric, endocrine, and pain-related disorders. In neuropsychiatry, nimodipine and isradipine, both L-type CCBs, show mood-stabilizing and neuroprot...
Saved in:
| Main Authors: | Aarish Manzar, Aleksandar Sic, Crystal Banh, Nebojsa Nick Knezevic |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/14/1114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Alteration of Microglial Calcium Homeostasis in Central Nervous System Disorders: A Comprehensive Review
by: Al Riyad Hasan, et al.
Published: (2024-10-01) -
The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
by: Muhammad Khizar Memon, et al.
Published: (2025-01-01) -
Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation
by: Ruqiang Yuan, et al.
Published: (2025-01-01) -
Biological computing with diffusion and excitable calcium stores
by: H. G. E. Hentschel, et al.
Published: (2004-02-01) -
Lercanidipine in general practice settings: safety and effectiveness. The LAPSE Study results
by: N. R. Robles, et al.
Published: (2010-10-01)